Skip to main content
. 2013 Aug 22;31(1):25–32. doi: 10.1007/s10585-013-9606-5

Fig. 2.

Fig. 2

Recurrence-free survival curve for patients with liver-only metastases who underwent radiofrequency ablation and chemotherapy (blue line) and patients with extrahepatic metastatic lesion who underwent the same treatment (green line). (Color figure online)